Fizer Pharmaceutical paid $78 million on January 2, 2021, for 6 million shares of Carne Cosmetics common stock. The investment represents a 25% interest in the net assets of Carne and gave Fizer the ability to exercise significant influence over Carnes operations. Fizer received dividends of $2 per share on December 21, 2021, and Carne reported net income of $28 million for the year ended December 31, 2021. The fair value of Carnes common stock at December 31, 2021, was $28.50 per share.

• The book value of Carne's net assets was $192 million.
• The fair value of Carne's depreciable assets exceeded their book value by $48 million. These assets had an average remaining useful life of twelve years.
• The remainder of the excess of the cost of the investment over the book value of net assets purchased was attributable to goodwill.

Required: Complete the table below and prepare the appropriate journal entries related to the investment during 2021.